Company / Net Income
Silence Therapeutics plc Net Income History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$45.3M
FY2025
5-year range
-$50.3M / -$45.3M
FY2024-FY2025
Trend
+10.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$45M in FY2025.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 10.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -22.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$45.3M | +10.0% |
| FY2024 | -$50.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026